基化蛋白:分子重量有多重要?
Diego Maria Michele Fornasari1
1Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, via Vanvitelli, 32, Milan, Italy. diegomariamichele.fornasari@gmail.com.
Clinical pharmacokinetics
|September 27, 2025
概括
聚乙烯甘醇 (PEGs) 通过增加半衰期和稳定性来增强治疗性蛋白质. PEG分子重量影响疗效和安全性,影响剂量频率和潜在积累.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
背景情况:
- 聚乙烯甘醇 (PEG) 是一种用于修改治疗性蛋白质的惰性聚合物.
- 基化可以提高蛋白质的溶解性,稳定性,并降低免疫性.
- 这种修改可以导致剂量更少的频率和改善患者的坚持.
研究的目的:
- 探索PEG分子重量和结构对PEGylated蛋白质特性的影响.
- 了解PEGylated治疗药物的药理动力学和安全性概况.
- 为了向临床实践提供有关PEGylated蛋白质使用的信息.
主要方法:
- 关于PEGylation及其对蛋白质疗法的影响的现有文献的审查.
- 分析PEG分子重量如何影响半衰期,清除和潜在毒性.
- 对PEG部分的免疫性和抗体形成的检查.
主要成果:
- 较高的PEG分子量通常会增加蛋白质的半衰期和稳定状态的时间.
- 随着分子重量的增加,PEGs的脏排泄减少,有利于胆道分泌.
- PEG积累和真空化可能会发生,特别是在PEG>30kDa的情况下,但通常在安全剂量下.
结论:
- PEG分子重量和结构是PEG基化蛋白安全性和有效性的关键决定因素.
- 了解这些因素对于优化治疗蛋白质设计和临床应用至关重要.
- 医生对PEG属性的认识有助于管理这些药物的药理学特征.
更多相关视频
11:32Characteristics of Precipitation-formed Polyethylene Glycol Microgels Are Controlled by Molecular Weight of Reactants
Published on: December 23, 2013
12.3K
10:00Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering SEC-MALS
Published on: June 20, 2019
57.6K
相关概念视频
01:10Polymers: Molecular Weight Distribution
4.7K
For any given polymer, the weight average molecular weight (Mw) is higher than, if not equal to, the number average molecular weight (Mn). The only situation in which the weight average molecular weight and the number average molecular weight are equal is when a polymer consists only of chains with equal molecular weight. However, this never happens in a synthetic polymer, since it is difficult to control the polymerization process up to a molecular level with accuracy to a hundred percent.
4.7K
01:01Polymers: Defining Molecular Weight
3.7K
Unlike small molecules with definite molecular weights, polymers are a mixture of individual polymer chains of varying lengths, each with a unique molecular weight. So, the molecular weight of a polymer is expressed as an average value based on the average size of the polymer chains. The two most common forms of averages used for polymers are the number average molecular weight and weight average molecular weight.
The number average molecular weight (Mn) is the summation of the number...
The number average molecular weight (Mn) is the summation of the number...
3.7K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
524
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
524
01:08Molecular Weight of Step-Growth Polymers
2.7K
Step growth polymerization involves bi or multifunctional monomers. Bifunctional monomers react to form linear step growth polymers, whereas multifunctional monomers react to form non-linear or branched polymers.
As the step-growth polymerization involves step-wise condensation of monomers, the molecular weight also builds up eventually. Consequently, high molecular weight polymers are obtained at the late stages of the polymerization, where 99% of monomers have been consumed.
The extent of the...
As the step-growth polymerization involves step-wise condensation of monomers, the molecular weight also builds up eventually. Consequently, high molecular weight polymers are obtained at the late stages of the polymerization, where 99% of monomers have been consumed.
The extent of the...
2.7K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
453
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
453
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
305
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
305